| For: | Liu Y, Chang J, Bai LD. Intestinal flora: New perspective of type 2 diabetes. World J Clin Cases 2024; 12(11): 1996-1999 [PMID: 38660554 DOI: 10.12998/wjcc.v12.i11.1996] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i11/1996.htm |
| Number | Citing Articles |
| 1 |
Yongqing Chen, Guangxu Wen, Hongmei Wang, Qiyu Yang, Zilang Luo, Xin Wang, Jing Ouyang, Jiadan Yang. Nomogram-based risk prediction model employing serum biomarkers to assess intestinal injury risk in patients with metabolic syndrome. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1579833
|
| 2 |
Tawhidul Islam, Nazim Uddin. Treatment of Type 2 Diabetes: A Comprehensive Review of Recent Improvements, Therapeutic Strategies, Challenges, and Future Perspectives. EMJ Diabetes 2025; : 72 doi: 10.33590/emjdiabet/RKYO7834
|
| 3 |
Brandon T. Grover, Salvatore Docimo, Thomas H. Shin, Timothy Shope, Vance L. Albaugh, Rachel Byers, Heather Passerini, C. Joe Northup, R. Wesley Vosburg. American Society of Metabolic and Bariatric Surgery review of gut microbiome and alterations related to weight loss treatment, by the Clinical Issues Committee. Surgery for Obesity and Related Diseases 2025; doi: 10.1016/j.soard.2025.11.021
|
| 4 |
Yecheng Gao, Yanfang Liu, Zelong Li, Liyi Lu, Yajuan Guo, Dun Su, Heping Zhang, Promi Das. Multi-strain probiotics attenuate carbohydrate-lipid metabolic dysregulation in type 2 diabetic rats via gut-liver axis modulation. mSystems 2025; 10(7) doi: 10.1128/msystems.00369-25
|
